8-K 1 a2091782z8-k.txt 8-K ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------- FORM 8-K CURRENT REPORT FILED PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): OCTOBER 22, 2002 ENCHIRA BIOTECHNOLOGY CORPORATION (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) DELAWARE 0-21130 04-3078857 (STATE OR OTHER JURISDICTION OF (COMMISSION FILE NUMBER) (I.R.S. EMPLOYER INCORPORATION OR ORGANIZATION) IDENTIFICATION NO.) 4200 RESEARCH FOREST DRIVE THE WOODLANDS, TEXAS 77381 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES AND ZIP CODE) (281) 419-7000 (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE) ---------------- ================================================================================ ITEM 5. OTHER EVENTS On October 22, 2002, Enchira Biotechnology Corporation (the "Company") issued a press release announcing that the Nasdaq Listing Qualifications Panel has declined the Company's request for additional time to regain compliance with the Nasdaq SmallCap listing requirements. Accordingly, the Panel determined to delist the Company's securities from the Nasdaq Stock Market effective with the open of business October 22, 2002. Efforts are underway for the stock to begin trading on the OTC Bulletin Board. The press release disclosing such determination is filed as an exhibit to this Current Report on Form 8-K and is incorporated by reference herein. ITEM 7. EXHIBITS Exhibit 99.1 -- Press Release SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ENCHIRA BIOTECHNOLOGY CORPORATION Date: October 22, 2002. By: /s/ PAUL G. BROWN, III --------------------------------------------- Paul G. Brown, III President, Chief Financial Officer and Vice President, Finance and Administration